TTBIO CORP. Statistics
TTBIO CORP. (6493) Stock Statistics & Valuation Metrics
Total Valuation
TTBIO CORP. has a market cap or net worth of TWD 853.42M. The enterprise value is ―.
- Market Cap
- TWD 853.42M
- Enterprise Value
- ―
Share Statistics
TTBIO CORP. has 30,050,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 30,050,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TTBIO CORP.’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -3.92%.
- Return on Equity (ROE)
- -0.06
- Return on Assets (ROA)
- -0.03
- Return on Invested Capital (ROIC)
- -3.92%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 2.89M
- Profits Per Employee
- -154.35K
- Employee Count
- 138
- Asset Turnover
- 0.64
- Inventory Turnover
- 1.25
Valuation Ratios
The current PE Ratio of TTBIO CORP. is -52.82. TTBIO CORP.’s PEG ratio is 0.01.
- PE Ratio
- -52.82
- PS Ratio
- 2.01
- PB Ratio
- 2.42
- Price to FCF
- -9.87
- Price to Operating Cash Flow
- -11.47
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, TTBIO CORP. had revenue of 398.88M and earned -21.30M in profits. Earnings per share was -0.79.
- Revenue
- 398.88M
- Gross Profit
- 49.76M
- Operating Income
- -21.23M
- Pretax Income
- -21.13M
- Net Income
- -21.30M
- EBITDA
- 14.81M
- Earnings Per Share (EPS)
- -0.79
Cash Flow
In the last 12 months, operating cash flow was -76.14M and capital expenditures -12.27M, giving a free cash flow of -88.41M billion.
- Operating Cash Flow
- -76.14M
- Free Cash Flow
- -88.41M
- Free Cash Flow per Share
- -2.94
Dividends & Yields
TTBIO CORP. pays an annual dividend of ―, resulting in a dividend yield of 0.70%
- Dividend Per Share
- ―
- Dividend Yield
- 0.70%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.18%
- Earnings Yield
- -1.69%
Stock Price Statistics
- Beta
- 1.24
- 52-Week Price Change
- -10.69%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 26.92
- Average Volume (3m)
- 73.80K
Financial Position
TTBIO CORP. as a current ratio of 2.37, with Debt / Equity ratio of 49.00%
- Current Ratio
- 2.37
- Quick Ratio
- 0.76
- Debt to Market Cap
- 0.16
- Net Debt to EBITDA
- 8.20
- Interest Coverage Ratio
- -3.89
Taxes
In the past 12 months, TTBIO CORP. has paid 171.00K in taxes.
- Income Tax
- 171.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
TTBIO CORP. EV to EBITDA ratio is 77.46, with an EV/FCF ratio of -11.61.
- EV to Sales
- 2.37
- EV to EBITDA
- 77.46
- EV to Free Cash Flow
- -11.61
- EV to Operating Cash Flow
- -13.49
Balance Sheet
TTBIO CORP. has TWD 92.15M in cash and marketable securities with TWD 250.43M in debt, giving a net cash position of -TWD 158.28M billion.
- Cash & Marketable Securities
- TWD 92.15M
- Total Debt
- TWD 250.43M
- Net Cash
- -TWD 158.28M
- Net Cash Per Share
- -TWD 5.27
- Tangible Book Value Per Share
- TWD 11.09
Margins
Gross margin is 12.09%, with operating margin of -5.31%, and net profit margin of -3.39%.
- Gross Margin
- 12.09%
- Operating Margin
- -5.31%
- Pretax Margin
- -3.27%
- Net Profit Margin
- -3.39%
- EBITDA Margin
- 3.06%
- EBIT Margin
- -5.31%
Analyst Forecast
The average price target for TTBIO CORP. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.36%
- EPS Growth Forecast
- -4614.66%
